Detalhe da pesquisa
1.
Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D.
N Engl J Med;
2024 Jun 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38842520
2.
A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D.
N Engl J Med;
389(1): 22-32, 2023 Jul 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37345876
3.
Reappraisal of the conventional hemostasis tests as predictors of perioperative bleeding in the era of rebalanced hemostasis in cirrhosis.
Hepatology;
2024 Jan 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38214562
4.
Safety and efficacy of off-label bulevirtide monotherapy in patients with HDV with decompensated Child-B cirrhosis-A real-world case series.
Hepatology;
2024 Mar 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38478755
5.
Quantification of circulating HBV RNA expressed from intrahepatic cccDNA in untreated and NUC treated patients with chronic hepatitis B.
Gut;
73(4): 659-667, 2024 Mar 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37879886
6.
Chronic Hepatitis B Finite Treatment: Similar and Different Concerns With New Drug Classes.
Clin Infect Dis;
78(4): 983-990, 2024 Apr 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37633256
7.
A new clinical and prognostic characterization of the patterns of decompensation of cirrhosis.
J Hepatol;
80(4): 603-609, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38110003
8.
JNJ-73763989 and bersacapavir treatment in nucleos(t)ide analog suppressed patients with chronic hepatitis B: REEF-2.
J Hepatol;
2024 Apr 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38583491
9.
PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B.
J Hepatol;
80(1): 20-30, 2024 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37734683
10.
Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis.
J Hepatol;
2024 May 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38782120
11.
Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase 3 randomized trial.
J Hepatol;
2024 May 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38734383
12.
Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipients.
J Hepatol;
80(1): 109-123, 2024 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37863203
13.
Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference.
Hepatology;
78(5): 1654-1673, 2023 11 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37326326
14.
HDV RNA assays: Performance characteristics, clinical utility, and challenges.
Hepatology;
2023 Aug 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37640384
15.
Prevalence of HCV infection in Europe in the DAA era: Review.
Liver Int;
2024 May 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38804727
16.
Quantification of serum HDV RNA by Robogene 2.0 in HDV patients is significantly influenced by the extraction methods.
Liver Int;
44(3): 831-837, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38247385
17.
Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection.
Gut;
72(7): 1385-1398, 2023 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36697207
18.
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro.
Gut;
72(11): 2123-2137, 2023 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36717219
19.
Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference.
J Hepatol;
79(5): 1254-1269, 2023 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37377088
20.
A 3-Year Course Of Bulevirtide Monotherapy May Cure Hdv Infection In Cirrhotics.
J Hepatol;
2023 Jan 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36931396